Research Products & Services
RiboMed provides a variety of versatile bisulfite-free research tools and services for the study of CpG methlyation in DNA.
• MethylMeter®: Quantitative DNA Methylation Detection
• MethylMagnet®: Ultra Sensitive Methylated DNA isolation
• CAP: Pioneering ”Coupled Abscription PCR ” DNA Methylation Detection
Clinical Diagnostics
RiboMed’s proprietary Abscription®-based DNA methylation diagnostic tests are leading the way in epigenetic and cancer diagnostics.
• Proprietary bisulfite free DNA Methylation Detection Clinical Diagnostic Assay Platform
• Theranostic Ovarian Cancer Assay
Latest News
June 12, 2013 RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response
RiboMed Receives Notice of Allowance for Three New Patents (a) Detecting CpG Methylation With a Methyl CpG Binding Protein (b) Molecular Beacon Abscription Detection (c) Abscription-Based Molecular Detection



